Back to search results

HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

Abroad (travel likely)RecruitingPHASE1

Conditions

Human Papillomavirus Type 16 · Cervical Intraepithelial Neoplasia Grade II · Cervical Intraepithelial Neoplasia, Grade III

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Alabama at Birmingham, Birmingham, Alabama, United States

    Contact: Study coordinator (Warner K Huh, MD) · whuh@uabmc.edu
    Contact: Study coordinator (Rebecca C Arend, MD, MSPH) · rarend@uabmc.edu · 2059344986
    Contact: Principal Investigator (Warner K Huh, MD)

  • Johns Hopkins University, Baltimore, Maryland, United States

    Contact: Study coordinator (Kimberly Levinson, MD, MPH) · klevins1@jhmi.edu
Study leads

  • Kimberly Levinson, MD

    Principal Investigator

    Johns Hopkins University

View source on ClinicalTrials.gov(opens in a new tab)